Author:
Lin Yu-Tsai,Wang Hung-Chen,Chuang Hui-Ching,Hsu Yi-Chiang,Yang Ming-Yu,Chien Chih-Yen
Funder
Kaohsiung Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Reference36 articles.
1. Salehiniya H, Mohammadian M, Mohammadian-Hafshejani A, Mahdavifar N (2018) Nasopharyngeal cancer in the world: epidemiology, incidence, mortality and risk factors. WCRJ 5:e1046
2. Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH (2013) Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol 82:366–373
3. Su WH, Hildesheim A, Chang YS (2013) Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol 3:299
4. Liao KC, Tsai WL, Fang FM (2017) Quality of life and quality-adjusted life expectancy for patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy - predictive values of clinical stages. IJHNS 1:131–140
5. Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS et al (2005) Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong nasopharyngeal carcinoma study group. Head & Neck 27:397–405
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献